The results suggest the drug boasts similar safety and efficacy in non-small cell lung cancer compared with the field’s ...

Merck headquarters in Rahway, NJ. RAWAY, N.J. – Merck today announced fourth quarter earnings and revenue that beat Wall Street estimates. However, Merck, the giant pharmaceutical company with ...

Merck (NYSE:MRK) received expanded EU approval for KEYTRUDA-based regimens in platinum-resistant ovarian cancer, making it ...

Merck (NYSE:MRK) is a global leader in healthcare and pharmaceuticals, contributing significantly to the Russell 1000 Index.

The pharmaceutical giant is finding ways to navigate despite headwinds. This has helped the shares outperform the market over the past year. Income investors should be pleased with Merck's dividend ...

Merck built a wall of patents that keeps a cancer drug's price – and its profits – high. Hospitals often add to the cost for ...

Merck Group's parent company, E. Merck KG, has announced the appointment of Kai Beckmann as the new chairman of the executive board and CEO, effective May 1, 2026. Beckmann will succeed Belen Garijo, ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

Merck Receives Positive EU CHMP Opinion for Expanded Use of WINREVAIR™ (sotatercept) in Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1 Pulmonary Hypertension) Merck (NYSE: MRK), known ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corp., Alibaba Group ...

Get the live share price of Merck & Company Inc (MRK), including intraday charts, historical performance, key financials, and ...